4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-018518
Options or other derivatives
- Director acquired 25,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Agger Mette Kirstine Director | 2025-06-26 | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | D | ||
Loading xslF345X05/form4-06302025_050601.xml…